Latest AmpliMed Stories
AmpliMed, a cancer therapeutics company, has entered into a license agreement with Korean-based pharmaceutical company Handok Pharmaceuticals for exclusive rights to its investigational cancer therapeutic Amplimexon in Korea. Under terms of the agreement, Handok will receive marketing and distribution rights to all cancer indications for Amplimexon in Korea and will pay AmpliMed an up-front fee plus additional payments based upon the achievement of certain development and regulatory...
- Exultant; jubilant; triumphant; on the high horse.
- Tipsy; slightly intoxicated.